Core Specialty Files for NYSE Listing
Core Specialty Insurance Holdings, Inc. has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission, signaling its intent to list on the New York Stock Exchange under the ticker symbol “CORE.” The offering, led by J.P. Morgan, Goldman Sachs, and BMO Capital Markets, is designed to create a public market for the company’s common stock and facilitate future access to public equity markets. Notably, the company is not raising new capital through this offering; instead, the shares are being sold by existing stockholders, including the private equity firms and institutional investors that supported the company's 2020 recapitalization.
The insurer, which identifies itself as the fourth-largest pure-play specialty insurer in the U.S. by gross written premium, has experienced significant growth since its formation in November 2020. That year, founder Jeff Consolino led a $900 million recapitalization of StarStone US Holdings, backed by SkyKnight Capital, Dragoneer Investment Group, and Aquiline Capital Partners, with Enstar Group retaining a stake. As of September 30, SkyKnight and Dragoneer held a combined 43% stake, while Enstar’s vehicle, Cavello Bay Reinsurance Limited, held approximately 20%.
Financial performance has improved, with gross written premium rising from $457 million in 2020 to $4.57 billion in 2025. For the nine months ending September 30, 2026, the company reported a combined ratio of 93.0%, an improvement from 98.2% during the same period the previous year. The company operates across 17 divisions, writing roughly 70% of its business on an admitted basis and 30% on an excess and surplus lines basis. Its primary property and casualty subsidiaries hold an “A” (Excellent) financial strength rating from AM Best. The company also disclosed a material weakness in internal controls that it is currently working to remediate.
The company’s reliance on distribution partners is significant, with three wholesale brokers accounting for 39% of gross written premium during the nine months ended September 30. Core Specialty noted that consolidation among these partners is a trend that could materially impact future results. As the company moves toward a public listing, it joins other specialty insurers like Ategrity Specialty and Orion180 in navigating an investor climate where the valuation of specialty insurance businesses remains a subject of scrutiny as the hard market cycle moderates.
For industry observers, this filing highlights the ongoing exit strategies for private equity firms in the insurance space. While Core Specialty’s scale and diversification distinguish it from recent market entrants, the transition to public ownership will subject its broker-dependent business model and internal controls to the heightened transparency and quarterly reporting requirements of the public markets.
Why it matters
The listing provides a liquidity event for major private equity backers and subjects the insurer's business model to public market scrutiny.
FAQ
Is Core Specialty raising new capital through this NYSE listing?
No, the company is not selling shares or receiving proceeds; the offering is solely for existing stockholders to reduce their stakes.
Who are the primary private equity backers of Core Specialty?
The company was backed by SkyKnight Capital, Dragoneer Investment Group, and Aquiline Capital Partners, with Enstar Group also retaining a stake.
What is the company's current financial strength rating?
Its primary property and casualty subsidiaries hold an “A” (Excellent) financial strength rating from AM Best.
Source: Insurance Business America. See the original source for full details.
Scan with your phone
Scan with your phone